Revision: Dec. 31, 2018, 1:07 p.m.
HB 359 - AS INTRODUCED
2019 SESSION
19-0787
01/04
HOUSE BILL 359
AN ACT relative to warning labels on prescription drugs containing opiates.
SPONSORS: Rep. Loughman, Rock. 21; Rep. Gourgue, Straf. 25; Rep. Josephson, Graf. 11; Rep. Griffith, Hills. 18; Rep. Muscatel, Graf. 12; Sen. Sherman, Dist 24; Sen. Reagan, Dist 17; Sen. Rosenwald, Dist 13
COMMITTEE: Commerce and Consumer Affairs
-----------------------------------------------------------------
ANALYSIS
This bill requires any drug which contains an opiate dispensed by a health care provider or pharmacy to have a red cap and a warning label regarding the risks of the drug.
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Explanation: Matter added to current law appears in bold italics.
Matter removed from current law appears [in brackets and struckthrough.]
Matter which is either (a) all new or (b) repealed and reenacted appears in regular type.
19-0787
01/04
STATE OF NEW HAMPSHIRE
In the Year of Our Lord Two Thousand Nineteen
AN ACT relative to warning labels on prescription drugs containing opiates.
Be it Enacted by the Senate and House of Representatives in General Court convened:
1 New Section; Controlled Drugs Containing Opiates; Warning Label Required. Amend RSA 318-B by inserting after section 16 the following new section:
318-B:16-a Controlled Drugs Containing Opiates; Warning Label Required. Any controlled drug containing opiates dispensed by a health care provider or pharmacy shall have a red cap and shall have a warning label disclosing that the drug is an opiate and explaining the risks of addiction and death.
2 Effective Date. This act shall take effect January 1, 2020.